Clinical utility of temozolomide in the treatment of malignant paraganglioma: A preliminary report

Hormone and Metabolic Research

Volumn 41, Issue 9, 2009, Pages 703-706

  Bravo, E L ^a   Kalmadi, S R ^b   Gill, I ^a,c,d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c Ironwood Cancer and Research Center   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Catecholamine production; Chemotherapy; Hepatic function; Pheochromocytoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ATENOLOL; DOPAMINE; DOXAZOSIN; ELECTROLYTE; HEMOGLOBIN; NORADRENALIN; NORMETADRENALIN; PROCHLORPERAZINE MALEATE; TEMOZOLOMIDE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE REGULATION; BONE MARROW EXAMINATION; CARDIOVASCULAR RESPONSE; CASE REPORT; CATECHOLAMINE SYNTHESIS; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ELECTROLYTE BLOOD LEVEL; EVENING DOSAGE; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY FUNCTION; LIVER METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA; ORTHOSTATIC HYPOTENSION; PARAGANGLIOMA; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SHORT COURSE THERAPY; SIDE EFFECT; SINGLE DRUG DOSE; THROMBOCYTE COUNT; TREATMENT OUTCOME; WEIGHT GAIN;

ADRENAL GLAND NEOPLASMS; ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; FEMALE; HUMANS; MIDDLE AGED; PARAGANGLIOMA;

EID: 70350359076     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1224135     Document Type: Article

References (11)

1. Averbuch S, Steakley C, Young R, Gelmann EP, Goldstein DS, Stull R, Keiser HR. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 1988 109 267-374
2. Huang H, Abraham J, Hung E, Averbuch S, Merino M, Steinberg SM, Pacak K, Fojo T. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. Cancer 2008 113 2020-2028
3. Fitoussi O, Debled M, Masson B, Coindre JM, Kantor G, Bui BN. Advanced paraganglioma: a role for chemotherapy? Med Paediatr Oncol 1999 33 129-131
4. Pipas JM, Krywicki RF. Treatment of progressive metastic glomus jugulare tumor (paraganglioma) with gemcitabine. Neuro Oncol 2000 2 190-191
5. Kruijtzer CM, Beijnen JH, Swart M, Schellens JH. Successful treatment with paclitaxel of a patient with metastatic extra-adrenal pheochromocytoma (paraganglioma). A case report and review of the literature. Cancer Chemother Pharmacol 2000 45 428-431
6. Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB. The diagnosis and management of malignant pheochromocytoma and paraganglioma. Endocr Relat Cancer 2007 14 569-585
7. Joshua AM, Shereen E, Asa SL, Evans A, Broom R, Freeman M, Knox JJ. Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma. J Clin Endocrinol Metab 2009 94 5-9
8. Stevens MFG, Hickman JA, Langdom SP, Chubb D, Vickers L, Stone R, Baig G, Goddard C, Gibson NW, Slack JA, Newton C, Lunt E, Fitames C, Lavelle F. Antitumor activity and pharmocokinetics in mice of 8-carbamoyl-3-methyl- imidazole[5-1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG81245; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res 1987 47 5846-5852
9. Middleton M, Grob J, Aaronson N, Fierlbeck G, Tilgen W, Seifer S, Gore M, Aamdal S, Cebon J, Coates A, Dreno B, Henz M, Schadendorf D, Kapp A, Weiss J, Fraass U, Statkevich P, Muller M. Thatcher N. Randomized phase III study of Temozolomide versus dacarbazine in the treatment of patients with advanced metastic melanoma. J Clin Oncol 2000 18 158-166 Erratum in J Clin Oncol 2000; 18: 2351. Comments in J Clin Oncol 2000; 18: 2185 (Pubitemid 30036349)
10. Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. The European Organization for Research and Treatment of Cancer Brain Tumor and Radiotherapy Group and the National Cancer Institute of Canada Clinical Trials Group. Radiotherpay plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med 2005 352 987-996
11. Kulke MH, Stuart K, Enzinger PC, Ryan DP, Clark JW, Muzikansky A, Vincitore M, Michelini A, Fuchs CS. Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J Clin Oncol 2006 24 401-406 (Pubitemid 46630459)